At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 24 enrolled
Drug / intervention
Zinc sulfatedrug
Likely dose
Zinc sulfate 200 mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Safety and Dose-escalation Study of Zinc Supplementation in Pediatric Critical Illness
In Brief
A Phase 2 clinical trial evaluating Zinc sulfate for Critical Illness. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The purpose of the study is 1) to determine whether administration of intravenous zinc to critically ill children is safe, and 2) to determine an appropriate dose of zinc supplementation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCritical Illness
CountriesUnited States
CollaboratorsChildren's Hospital Medical Center, Cincinnati
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2008
First PostedFeb 2010
Primary CompletionOct 2014
Study CompletionNov 2014
TodayJul 2026
First PostedFeb 4, 2010
Enrollment StartNov 1, 2008
Primary CompletionOct 1, 2014
Study CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 16.4 years ago
Interventions
Zinc sulfatedrug
Zinc sulfate 200 mcg/ml in Normal Saline